Phase separation liquid-liquid extraction for the quantification of 8-iso-Prostaglandin F2 Alpha in human plasma by LC-MS/MS

Quantitative analysis of therapeutic proteins in biological fluids: recent advancement in analytical techniques

Pharmaceutical application of therapeutic proteins has been continuously expanded for the treatment of various diseases. Efficient and reliable bioanalytical methods are essential to expedite the identification and successful clinical development of therapeutic proteins. In particular, selective quantitative assays in a high-throughput format are critical for the pharmacokinetic and pharmacodynamic evaluation of protein drugs and to meet the regulatory requirements for new drug approval. However, the inherent complexity of proteins and many interfering substances presented in biological matrices have a great impact on the specificity, sensitivity, accuracy, and robustness of analytical assays, thereby hindering the quantification of proteins. To overcome these issues, various protein assays and sample preparation methods are currently available in a medium- or high-throughput format. While there is no standard or universal approach suitable for all circumstances, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay often becomes a method of choice for the identification and quantitative analysis of therapeutic proteins in complex biological samples, owing to its high sensitivity, specificity, and throughput. Accordingly, its application as an essential analytical tool is continuously expanded in pharmaceutical R&D processes. Proper sample preparation is also important since clean samples can minimize the interference from co-existing substances and improve the specificity and sensitivity of LC-MS/MS assays. A combination of different methods can be utilized to improve bioanalytical performance and ensure more accurate quantification. This review provides an overview of various protein assays and sample preparation methods, with particular emphasis on quantitative protein analysis by LC-MS/MS.

Packed-Fiber Solid Phase-Extraction Coupled with HPLC-MS/MS for Rapid Determination of Lipid Oxidative Damage Biomarker 8-Iso-Prostaglandin F2α in Urine

The 8-iso-prostaglandin F2α (8-iso-PGF2α) biomarker is used as the gold standard for tracing lipid oxidative stress in vivo. The analysis of urinary 8-iso-PGF2α is challenging when dealing with trace amounts of 8-iso-PGF2α and the complexity of urine matrixes. A packed-fiber solid-phase extraction (PFSPE)−coupled with HPLC-MS/MS−method, based on polystyrene (PS)-electrospun nanofibers, was developed for the specific determination of 8-iso-PGF2α in urine and compared with other newly developed LC-MS/MS methods. The method, which simultaneously processed 12 samples within 5 min on a self-made semi-automatic array solid-phase extraction processor, was the first to introduce PS-electrospun nanofibers as an adsorbent for the extraction of 8-iso-PGF2α and was successfully applied to real urine samples. After optimizing the PFSPE conditions, good linearity in the range of 0.05−5 ng/mL with R2 > 0.9996 and a satisfactory limit of detection of 0.015 ng/mL were obtained, with good intraday and interday precision (RSD < 10%) and recoveries of 95.3−103.8%. This feasible method is expected to be used for the batch quantitative analysis of urinary 8-iso-PGF2α.

Oxidative Stress in the Oral Cavity before and After Prosthetic Treatment

BACKGROUND: Metal ions emitted from dental alloys may induce oxidative stress leading to numerous pathological changes. Lipid peroxidation may cause disturbance of structure and function of cell membranes, apoptosis, autophagy, and formation of potentially mutagenic compounds. Products of interaction between reactive oxygen species and biomolecules may be used for evaluation of oxidative stress level. AIM: The aim of this study was to evaluate the influence of the prosthetic dental treatment with metal ceramic restorations on the level of oxidative stress in the oral cavity. MATERIALS AND METHODS: Metal ceramic crowns with copings fabricated by direct metal laser sintering were produced for 35 patients. CoCr dental alloy EOS CobaltChrome SP2 (EOS) was used. Non-stimulated and stimulated saliva samples were collected from the patients before and after the prosthetic treatment. For evaluation of oxidative stress concentration of 8-isoPGF2-alpha was measured by liquid chromatography tandem mass spectrometry. For statistical processing, non-parametric Wilcoxon signed-rank test and Mann–Whitney test were applied. RESULTS: The concentration of isoprostane 8-isoPGF2-alpha in non-stimulated saliva was lower 2 h after fixing the crowns compared to the initial level and statistically significant difference was observed. On the 7th day the concentration of isoprostanes remained significantly lower than the initial one. No significant differences were found in isoprostane concentration in stimulated saliva before and after prosthetic treatment. CONCLUSION: Prosthetic dental treatment leads to decrease in oral oxidative stress.